Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04892017
Title A Safety, Tolerability and PK Study of DCC-3116 in Patients With RAS or RAF Mutant Advanced or Metastatic Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Deciphera Pharmaceuticals LLC
Indications

pancreatic ductal adenocarcinoma

colorectal cancer

Advanced Solid Tumor

melanoma

lung non-small cell carcinoma

Therapies

DCC-3116

DCC-3116 + Trametinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST